Joyce Lee, Pharm.D.

Joyce S. Lee, Pharm.D.


Oncology Pharmacy

Pharmaceutical Development


  • Clinical Pharmacist
  • Assistant Adjunct Professor, Department of Internal Medicine, Division of Hematology and Oncology


To see if Joyce S. Lee is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

4501 X St.
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Phone: 916-734-7176
Fax: 916-734-2260
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Research/Academic Interests

Research interests: Nanotherapeutics for cancer therapy Educational interests: investigational drug management



Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


Pharmacy, Albany College of Pharmacy, Albany NY 1996

Parm.D., Clinical Pharmacy, University of Florida, Gainsville FL 2005

Internship: Pharmacy/ Pharmacy Practice, UC Davis Medical Center, Sacramento CA 2007


Pharmacy/Oncology Pharmacy Specialty, UC Davis Medical Center, Sacramento CA 2008


Internal Medicine, Division of Hematology and Oncology/Translational Research, UC Davis Medical Center, Sacramento CA 2010

Board Certifications

Oncology Pharmacist, 2008

Pharmacotherapy Specialist, 2007

Professional Memberships

American Association of Cancer Research

American Society of Clinical Oncology

Hematology/Oncology Pharmacy Assocation

Southwest Oncology Group

Honors and Awards

Hyundai Hope on Wheels Pediatric Cancer Research Young Scholar Award/ Hyundai, 2011

UC Davis 15th Cancer Research Symposium, Poster Presentation Award, 2010

Select Recent Publications

Nicholas J. Kenyon, Jennifer M. Bratt, Joyce Lee, Juntao Luo, Lisa M. Franzi, Amir A. Zeki, Kit S Lam. Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation. PLOS ONE, 2013;8(10): 1-11.

Kato, J, Li, Y, Xiao, K,Lee, JS, Luo, J, Tuscano, JM, O'Donnell, RT,Lam, KS. Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphoma. Molecular pharmaceutics, 2012;9(6):1727-35.

Xiao, K, Li, Y, Lee, JS, Gonik, AM, Dong, T, Fung, G, Sanchez, E, Xing, L, Cheng, HR, Luo, J, Lam, KS. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Cancer research, 2012;72(8): 2100-10.

S. Amin and J. Lee; J Avila, M. Boron, S. Conley, R. Enos, K. Galus, T. Mays, G. Patil, J.Thompson: HOPA Investigational Drug Service Best Practice Standards, Hematology/Oncology Pharmacy Association. 2014.

Lee, J, Lam, KS. Perspectives on clinical translation of smart nanotherapeutics. Therapeutic delivery, 2012;3 (12) 1359-62.